HLM006474

HLM006474 Struktur
353519-63-8
CAS-Nr.
353519-63-8
Englisch Name:
HLM006474
Synonyma:
CS-1224;HLM006474;E2F Inhibitor, HLM006474 - CAS 353519-63-8 - Calbiochem;HLM006474,inhibit,HLM 006474,Early 2 Factor (E2F),Inhibitor,HLM-006474;7-((4-Ethoxy-3-methylphenyl)(pyridin-2-ylamino)methyl)-2-methylquinolin-8-ol;8-Quinolinol, 7-[(4-ethoxy-3-methylphenyl)(2-pyridinylamino)methyl]-2-methyl-
CBNumber:
CB92715640
Summenformel:
C25H25N3O2
Molgewicht:
399.48
MOL-Datei:
353519-63-8.mol

HLM006474 Eigenschaften

Siedepunkt:
588.7±50.0 °C(Predicted)
Dichte
1.227±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
Löslichkeit
DMSO:25.0(Max Conc. mg/mL);62.58(Max Conc. mM)
pka
4.36±0.50(Predicted)
Aggregatzustand
Off-white solid
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H413 Kann für Wasserorganismen schädlich sein, mit langfristiger Wirkung. Langfristig (chronisch) gewässergefährdend Kategorie 4
Sicherheit

HLM006474 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

HLM006474 is a non-selective inhibitor of the transcription factor E2F (IC50 = 29.8 μM for E2F4). It inhibits DNA binding to E2F1, E2F2, and E2F4 in A375 melanoma cells when used at a concentration of 40 μM. HLM006474 (40 μM) decreases protein levels of E2F4 and cyclin D3 and induces apoptosis in A375 cells. It also induces apoptosis in MDA-MB-231, but not MCF-7, cells and inhibits the growth of cancer cells in a panel of 17 lung cancer cell lines (IC50s = 15.5-75.1 μM). HLM006474 reduces tumor growth in retinoblastoma-prone Chx10Cre;Rbfl/fl;p107-/- mice and in an A375 mouse xenograft model when administered at a dose of 100 mg/kg and 2 mg per mouse, respectively.

Verwenden

HLM006474 has been used as an E2 factor?(E2F) inhibitor in human nasopharyngeal carcinoma hone-1 cells and T. annulata-infected TBL20 cells.

Allgemeine Beschreibung

A cell-permeable 8-hydroxyquinoline compound that is reported to inhibit nuclear E2F complexes DNA binding activity (IC50 = 30 μM) and downregulate E2F expression in the melanoma cell line A375, resulting in eventual apoptosis induction without upregulating p53 expression as commonly seen with traditional chemotherapeutic agents, such as Cisplatin (Cat. No. 232120), doxorubicin (Cat. No. 324380), and VP-16 (Cat. No. 341205).

HLM006474 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


HLM006474 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 65)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10523 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
Haoyuan Chemexpress Co., Ltd. 021-58950125
info@chemexpress.com China 7553 61
MedChemexpress LLC 021-58955995
sales@medchemexpress.cn United States 4863 58
LETOPHARM LIMITED +86-21-5821 5861
sales@letopharm.com China 2384 58
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4121 55
SPIRO PHARMA
eric_feng1954@126.com China 9254 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9709 58

  • HLM006474
  • E2F Inhibitor, HLM006474 - CAS 353519-63-8 - Calbiochem
  • CS-1224
  • 8-Quinolinol, 7-[(4-ethoxy-3-methylphenyl)(2-pyridinylamino)methyl]-2-methyl-
  • 7-((4-Ethoxy-3-methylphenyl)(pyridin-2-ylamino)methyl)-2-methylquinolin-8-ol
  • HLM006474,inhibit,HLM 006474,Early 2 Factor (E2F),Inhibitor,HLM-006474
  • 353519-63-8
Copyright 2019 © ChemicalBook. All rights reserved